Uncategorized

A bill introduced in the Senate last week by Sen. Debbie Stabenow (D-Mich.) and supported by Senate Majority Leader Harry Reid (D-Nev.) would stop next year's reductions in Medicare reimbursement rates to physicians, according to a report by the Los…

Melville, N.Y.-based Sequel Systems, a service-oriented healthcare technology company, announced the launch and general availability of SequelMed Patient Portal, a new, Web-based tool that is designed to improve communication between physicians and patients, giving patients instant access to their personal…

Monthly premiums for basic Medicare coverage could increase 15 percent next year for some beneficiaries, to $110.50 per month, according to a report by the New York Times.

CDW Healthcare, part of the public sector subsidiary of CDW Corp., and Cerner Corp., a global provider of healthcare solutions, announced an agreement for CDW to offer Cerner physician practice solutions, according to a CDW news release.

James T. Baker, MD, an orthopedic surgeon at Central Texas Medical Center in San Marcos, Texas, has been honored by the American Medical Association as a recipient of the 2010 Physician's Recognition Award, according to a report by Newstreamz San…

A physician, years ago, informed an audience that the life span of a surgery center was exactly 13 years. We had never put an exact time frame on it. That stated, his comments and thoughts resonated as often true. If…

Todd Swanson, MD, an orthopedic surgeon in Las Vegas, has been working with Smith & Nephew Orthopedics and other surgeons to design a new mini-stem total hip prosthesis for young patients, according to a release from Dr. Swanson.

The Cleveland Clinic's Orthopaedic and Rheumatologic Institute has added two orthopedic surgeons, Kenneth A. Greene, MD, and Joseph B. Scarcella, MD, according to the Sun.

Orthopedic surgeon Rory Farris, MD, has become the 21st physician at Southern Bone and Joint Specialists in Enterprise, Ala., according to a report by the Enterprise Ledger.

The FDA has rejected an application from Genentech and Biogen Idec to expand use of Rituxan, their rheumatoid arthritis treatment, to patients with earlier stages of the disease, according to a release from Genentech.